Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: A double-blind, randomized, crossover trial

American Journal of Clinical Nutrition

Volumn 103, Issue 6, 2016, Pages 1426-1433

  De Courten, Barbora ^a,c   De Courten, Maximilian P J ^d   Soldatos, Georgia ^a,c   Dougherty, Sonia L ^c   Straznicky, Nora ^c   Schlaich, Markus ^c   Sourris, Karly C ^c   Chand, Vibhasha ^a,c   Scheijen, Jean L J M ^e   Kingwell, Bronwyn A ^c   Cooper, Mark E ^c   Schalkwijk, Casper G ^e   Walker, Karen Z ^b,c   Forbes, Josephine M ^c,f  

^a Alfred Centre   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d VICTORIA UNIVERSITY   (Australia)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Glycotoxin; Insulin resistance; Insulin secretion; Obesity; Receptors for AGEs

Indexed keywords

6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; DICARBOXYLIC AMINO ACID; GLUCOSE; IMIDAZOLIDINE DERIVATIVE; INSULIN; METHYLGLYOXAL DERIVED HYDROIMADAZOLIDINE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; LYSINE; METHYLGLYOXAL; N(6)-CARBOXYETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LOW CALORY DIET; MACRONUTRIENT; MALE; MASS SPECTROMETRY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PLASMA; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TREATMENT DURATION; URINALYSIS; YOUNG ADULT; ANALOGS AND DERIVATIVES; ANALYSIS; BLOOD; DIET; DIET THERAPY; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MIDDLE AGED; PHYSIOLOGY; URINE;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMIDAZOLIDINES; INSULIN; INSULIN RESISTANCE; LYSINE; MALE; MIDDLE AGED; OVERWEIGHT; PYRUVALDEHYDE;

EID: 84973129895     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.125427     Document Type: Article

References (25)

1. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005; 81:341-54.
2. Henle T. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids 2005; 29:313-22.
3. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010; 110:911-16.e12.
4. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996; 271:9982-6.
5. Cai W, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci USA 2012; 109:15888-93.
6. Gaens KH, Goossens GH, Niessen PM, van Greevenbroek MM, van der Kallen CJ, Niessen HW, Rensen SS, Buurman WA, Greve JW, Blaak EE, et al. Ne-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. Arterioscler Thromb Vasc Biol 2014; 34:1199-208.
7. Roncero-Ramos I, Delgado-Andrade C, Tessier FJ, Niquet-Leridon C, Strauch C, Monnier VM, Navarro MP. Metabolic transit of N(e)-car-boxymethyl-lysine after consumption of AGEs from bread crust. Food Funct 2013; 4:1032-9.
8. Roncero-Ramos I, Niquet-Leridon C, Strauch C, Monnier VM, Tessier FJ, Navarro MP, Delgado-Andrade C. An advanced glycation end product (AGE)-rich diet promotes Ne-carboxymethyl-lysine accumulation in the cardiac tissue and tendons of rats. J Agric Food Chem 2014; 62:6001-6.
9. Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 2005; 54:2314-9.
10. Sebeková K, Somoza V, Jarcuskova M, Heidland A, Podracka L. Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes 2009; 4:112-8.
11. Song F, Hurtado del Pozo C, Rosario R, Zou YS, Ananthakrishnan R, Xu X, Patel PR, Benoit VM, Yan SF, Li H, et al. RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice. Diabetes 2014; 63:1948-65.
12. Sebeková K, Klenovics KS, Boor P, Celec P, Behuliak M, Schieberle P, Heidland A, Palkovits M, Somoza V. Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds. Physiol Behav 2012; 105:693-701.
13. Forbes JM, Cowan SP, Andrikopoulos S, Morley AL, Ward LC, Walker KZ, Cooper ME, Coughlan MT. Glucose homeostasis can be differentially modulated by varying individual components of a western diet. J Nutr Biochem 2013; 24:1251-7.
14. Zhao Z, Zhao C, Zhang XH, Zheng F, Cai W, Vlassara H, Ma ZA. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology 2009; 150:2569-76.
15. Coughlan MT, Yap FY, Tong DC, Andrikopoulos S, Gasser A, Thallas Bonke V, Webster DE, Miyazaki J, Kay TW, Slattery RM, et al. Advanced glycation end products are direct modulators of beta-cell function. Diabetes 2011; 60:2523-32.
16. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011; 34:1610-6.
17. Mark AB, Poulsen MW, Andersen S, Andersen JM, Bak MJ, Ritz C, Holst JJ, Nielsen J, de Courten B, Dragsted LO, et al. Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care 2014; 37:88-95.
18. Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 2010; 91:1220-6.
19. de Courten B, de Courten MP, Schalkwijk CG, Walker KZ, Forbes J. Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: a study protocol for a double-blind, randomized, two period cross-over trial. JMIR Res Protoc 2015; 4:e93.
20. Scheijen JL, Clevers E, Engelen L, Dagnelie PC, Brouns F, Stehouwer CD, Schalkwijk CG Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: presentation of a dietary AGE database. Food Chem 2016; 190:1145-50.
21. Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Stehouwer CD, et al. Plasma levels of advanced glycation endproducts Nepsilon-(carboxymethyl)lysine, Ne-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. J Clin Endocrinol Metab 2013; 98:E1369-73.
22. Macías-Cervantes MH, Rodriguez-Soto JM, Uribarri J, Diaz-Cisneros FJ, Cai W, Garay-Sevilla ME. Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men. Nutrition 2015; 31:446-51.
23. Forbes JM, Sourris KC, de Courten MP, Dougherty SL, Chand V, Lyons JG, Bertovic D, Coughlan MT, Schlaich MP, Soldatos G, et al. Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects. Amino Acids 2014; 46:321-6.
24. Sebeková K, Krivosíková Z, Gajdos M. Total plasma Ne-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects. Clin Chem Lab Med 2014; 52:139-49.
25. Maessen DE, Hanssen NM, Scheijen JL, van der Kallen CJ, van Greevenbroek MM, Stehouwer CD, Schalkwijk CG Post-glucose load plasma a-dicarbonyl concentrations are increased in individuals with impaired glucose metabolism and type 2 diabetes: The CODAM Study. Diabetes Care 2015; 38:913-20.